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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.12.001Abstract Incidence of malignant ovarian germ cell tumors (MOGCTs) in the Saudi Arabian population has not
been studied before. Therefore, the primary objective of this study was to define the population-based incidence
rates and histopathological types of MOGCTs in the Saudi Arabian population from 1999 to 2008. Our study
showed that MOGCTs are a common type of ovarian tumors in the Saudi Arabian population, and the incidence
rates and histopathological types are relatively comparable to the international populations with few differences.HOvarian germ cell tumors (OGCTs) are rapidlygrowing neoplasms thought to originate fromprimitive germ cells of the embryonic gonad
ovary.1 OGCTs account for roughly 20–25% of all ovar-
ian tumors overall and can be benign or malignant.1
Malignant ovarian germ cell tumors (MOGCTs) are
exceedingly uncommon neoplasms accounting for
roughly 5% of all malignant ovarian tumors.1 Histopa-
thological classiﬁcation of MOGCTs include: dysgermi-
noma, germinoma, yolk sac (endodermal sinus) tumor,
malignant (immature) teratoma, embryonal carcinoma,
polyembryoma, primary ovarian (nongestational) chorio-
carcinoma and mixed germ cell tumor.2
Incidence of MOGCTs in the Saudi Arabian pop-
ulation has not been studied before. Therefore, the
primary objective of this study is to deﬁne the
population-based incidence and histopathological
types of MOGCTs in the Saudi Arabian population
from 1999 to 2008. Comprehensive details of MOG-
CTs are beyond the scope of research report and will
be addressed in a couple of future research projects.MATERIAL AND METHODS
1Using the Saudi Cancer Registry (SCR), we con-
ducted a retrospective cross-sectional study from
January 1999 to December 2008 to explore theematol Oncol Stem Cell Ther 7(1) First Quarter 2014 hemoncstem.edmgr.comfollowing epidemiological data: histopathological
types, frequency of cases, crude incidence rates
(CIRs), and age-standardized incidence rates (ASIRs)
of MOGCTs among the Saudi Arabian population.RESULTS
Among all female tumors diagnosed over the ten years
examined (n = 30,720), incidence of ovarian tumors
was 4.1% (n = 1271/30,720). MOGCTs speciﬁcally
accounted for 13.8% (n = 175/1271) of all ovarian
tumors overall.
Table 1 displays the distribution of MOGCT his-
topathological types in the Saudi Arabian population
from 1999 to 2008. Dysgerminoma was the most
common histopathological type of MOGCTs
accounting for approximately 41.1% (n = 72/175),
followed by malignant teratoma 25.1% (n = 44/175),
yolk sac tumor 18.3% (n = 32/175) and mixed germ cell
tumor 14.3% (n = 25/175).
Table 2 shows the total number of cases, CIRs and
world ASIRs of MOGCTs in the Saudi Arabian pop-
ulation from 1999 to 2008 adjusted by age. Around
60.5% of all MOGCT cases occurred in children
and young adolescents aged between 10 and 24 years
of age. Occurrence of MOGCTs in patients beyond
40 years of age was extremely low accounting for up41
Table 2. The total number of cases, crude incidence rates (CIRs), and world age-standardized incidence rates (ASIRs) of malignant ovarian germ cell tumors (MOGCTs) in the
Saudi Arabian population from 1999 to 2008 adjusted by age.
Yr All ages Un-known
age
0–4
Yr
5–9 Yr 10–14
Yr
15–19
Yr
20–24
Yr
25–29
Yr
30–34
Yr
35–39
Yr
40–44
Yr
45–49
Yr
50–54
Yr
55–59
Yr
60–64
Yr
65–69
Yr
70+
Yr
CIR ASIR
world
1999 21 0 0 1 5 3 5 4 1 1 0 1 0 0 0 0 0 0.3 0.3
2000 18 0 0 3 3 4 3 0 2 1 1 0 0 0 0 0 1 0.2 0.2
2001 14 0 0 0 4 4 1 2 1 0 1 0 0 1 0 0 0 0.2 0.2
2002 19 1 0 3 4 3 3 1 1 0 0 0 0 0 0 0 3 0.2 0.2
2003 22 0 1 3 3 5 5 2 1 2 0 0 0 0 0 0 0 0.3 0.2
2004 13 0 0 1 4 2 2 1 1 0 1 1 0 0 0 0 0 0.2 0.1
2005 16 0 0 4 4 4 2 2 0 0 0 0 0 0 0 0 0 0.2 0.1
2006 15 0 1 0 2 3 4 1 1 2 0 0 0 0 0 0 0 0.2 0.2
2007 19 0 0 3 5 6 3 1 0 0 0 0 0 0 0 0 1 0.2 0.2
2008 18 0 1 2 4 3 3 2 3 0 0 0 0 0 0 0 0 0.2 0.2
Total
(%)
175
(100)
1 (0.6) 3 (1.7) 20
(11.4)
38 (21.7)37 (21.1)31 (17.7) 16 (9.1) 11 (6.3) 6 (3.4) 3 (1.7) 3 (1.7) 0 (0) 1 (0.6) 0 (0) 0 (0) 5 (2.8) 0.2 0.2
Abbreviations: yr: year; CIR: crude incidence rate; ASIR: age-standardized incidence rate.
Table 1. The distribution of malignant ovarian germ cell tumor (MOGCT) histopathological types in the Saudi Arabian population from 1999 to 2008.
Year 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Total (%)
Histological type
Dysgerminoma 10 7 5 5 8 4 9 8 10 6 72 (41.1)
Embryonal carcinoma 0 0 0 2 0 0 0 0 0 0 2 (1.1)
Yolk sac tumor 2 2 3 6 4 4 2 1 2 6 32 (18.3)
Malignant teratoma 5 7 5 5 6 3 1 2 6 4 44 (25.1)
Mixed germ cell tumor 4 2 1 1 4 2 4 4 1 2 25 (14.3)
Total (%) 21 (12) 18 (10.3) 14 (8) 19 (10.9) 22 (12.6) 13 (7.4) 16 (9.1) 15 (8.6) 19 (10.9) 18 (10.3) 175 (100)
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brief communication INCIDENCE OF MOGCTS IN SAUDI ARABIAto 6.8%. CIRs and world ASIRs were almost similar
and did not differ signiﬁcantly.DISCUSSION
In our study, incidence of ovarian tumors (4.1%) was
fairly comparable to the worldwide incidence in Uni-
ted States and most developed countries (3%).3 More-
over, among ovarian tumors overall, incidence of
MOGCTs in the Saudi Arabian population (13.8%)
was approximately 3 times the incidence of Western
populations (5%) and roughly matched the incidence
of Asian and African populations (15%).4HeDysgerminoma was the most frequent histopathol-
ogical type comprising 41.1% of all MOGCTs in the
Saudi Arabian population. Our ﬁnding greatly
mirrored the worldwide incidence of dysgerminoma
(35–50%) as the most frequently diagnosed histopa-
thological type of MOGCTs.2 While dysgerminoma
accounts for less than 2% of all ovarian tumors
internationally,5 it accounted for roughly 5.7%
(n = 72/1271) of all ovarian tumors in the Saudi
Arabian population (around 3 folds higher).
Moreover, while ovarian malignant teratomas
account for less than 1% of all ovarian tumors and
roughly 20% of MOGCTs internationally,6 theymatol Oncol Stem Cell Ther 7(1) First Quarter 2014 hemoncstem.edmgr.com
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accounted for roughly 3.5% (n = 44/1271) of all ovar-
ian tumors (3.5 folds higher) and 25.1% of MOGCTs
in the Saudi Arabian population.
Furthermore, the estimated international incidence
of ovarian yolk sac tumor (20%) was comparatively
equivalent to our study ﬁndings of 18.3%.2 In addi-
tion, mixed germ cell tumors account for roughly
10% of all MOGCTs worldwide,2 and this percentage
was slightly higher in our study ﬁnding of 14.3%.
Polyembryoma and primary ovarian (nongesta-
tional) choriocarcinoma are extremely rare neoplasms
accounting for less than 1% of all MOGCTs interna-
tionally.2 In our study, no single case of ovarian poly-
embryoma or nongestational choriocarcinoma was
identiﬁed. They almost always exist in admixed forms
and hardly ever exist in solitary pure forms.7
Looking into Western literature, the reported
median age at time of clinical diagnosis of MOGCTs
is 18 years.8–10 This ﬁgure greatly paralleled our ﬁnd-
ing in which the vast majority of MOGCT cases
(60.6%) in the Saudi Arabian population occurred
in patients between 10 and 25 years of age. This
can be greatly attributed to the younger average age
group of the Saudi Arabian population. As
MOGCTs happen predominately in early children,
young adolescents, early-to-late adulthood, and
child-bearing age group women, the issues of fertility
preservation, tumor curability and long-term survival
rates are of great signiﬁcance to patients, and mark-
edly present difﬁcult management challenges to the
attending gynecologic oncologists.4
CONCLUSION
This is the ﬁrst study published documenting the
incidence and histopathological types of MOGCTsHematol Oncol Stem Cell Ther 7(1) First Quarter 2014 hemoncstem.edmgr.comin the Saudi Arabian population. This study conﬁrms
MOGCTs are a common type of ovarian tumors in
the Saudi Arabian population and the incidence rates
and histopathological types are relatively comparable
to the international populations with few differences.
Future research directions include exploring further
epidemiological facts, risk factors, clinical presenta-
tions (signs and symptoms), tumor biological behav-
iors, diagnostic blood markers and radiological
investigations, surgical management and fertility pres-
ervation, chemotherapy responses and overall progno-
sis of MOGCTs in Saudi Arabia. Additional research
objectives include MOGCT screening and early
detection programs. These studies are anticipated to
further our understanding of MOGCTs in Saudi
Arabia and accordingly optimize our practice towards
best approach of MOGCTs.ROLE OF FUNDING SOURCE
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